Nuveen LLC Makes New $22.98 Million Investment in Plexus Corp. $PLXS

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Nuveen LLC purchased a new position in shares of Plexus Corp. (NASDAQ:PLXS - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 179,313 shares of the technology company's stock, valued at approximately $22,975,000. Nuveen LLC owned approximately 0.66% of Plexus at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Aquatic Capital Management LLC raised its position in shares of Plexus by 134.0% in the fourth quarter. Aquatic Capital Management LLC now owns 234 shares of the technology company's stock valued at $37,000 after purchasing an additional 134 shares during the period. Versant Capital Management Inc raised its position in shares of Plexus by 1,000.0% in the first quarter. Versant Capital Management Inc now owns 473 shares of the technology company's stock valued at $61,000 after purchasing an additional 430 shares during the period. TD Private Client Wealth LLC raised its position in shares of Plexus by 185.6% in the first quarter. TD Private Client Wealth LLC now owns 514 shares of the technology company's stock valued at $66,000 after purchasing an additional 334 shares during the period. N.E.W. Advisory Services LLC bought a new position in shares of Plexus in the first quarter valued at about $87,000. Finally, Blue Trust Inc. raised its position in shares of Plexus by 49.2% in the first quarter. Blue Trust Inc. now owns 846 shares of the technology company's stock valued at $108,000 after purchasing an additional 279 shares during the period. 94.45% of the stock is owned by institutional investors.

Plexus Trading Up 4.9%

NASDAQ:PLXS traded up $6.3750 during mid-day trading on Friday, hitting $136.9250. 71,783 shares of the company's stock were exchanged, compared to its average volume of 179,169. The company has a 50 day simple moving average of $132.30 and a 200-day simple moving average of $130.17. The company has a current ratio of 1.58, a quick ratio of 0.74 and a debt-to-equity ratio of 0.06. Plexus Corp. has a fifty-two week low of $103.43 and a fifty-two week high of $172.89. The firm has a market capitalization of $3.70 billion, a P/E ratio of 23.36 and a beta of 0.80.

Plexus (NASDAQ:PLXS - Get Free Report) last posted its earnings results on Wednesday, July 23rd. The technology company reported $1.90 EPS for the quarter, topping the consensus estimate of $1.71 by $0.19. Plexus had a net margin of 4.04% and a return on equity of 12.33%. The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.02 billion. During the same period last year, the company earned $1.45 EPS. The firm's revenue was up 6.0% compared to the same quarter last year. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. As a group, research analysts expect that Plexus Corp. will post 5.9 earnings per share for the current year.

Insider Buying and Selling at Plexus

In related news, CEO Todd P. Kelsey sold 1,500 shares of Plexus stock in a transaction that occurred on Friday, August 1st. The shares were sold at an average price of $125.63, for a total transaction of $188,445.00. Following the sale, the chief executive officer directly owned 72,214 shares in the company, valued at $9,072,244.82. This trade represents a 2.03% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Patrick John Jermain sold 2,178 shares of Plexus stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $130.42, for a total transaction of $284,054.76. Following the sale, the chief financial officer owned 23,459 shares in the company, valued at approximately $3,059,522.78. This represents a 8.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 12,484 shares of company stock worth $1,626,335 over the last quarter. Insiders own 1.76% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on PLXS shares. Sidoti raised shares of Plexus from a "neutral" rating to a "buy" rating and increased their price objective for the company from $135.00 to $150.00 in a research report on Friday, July 25th. Stifel Nicolaus set a $140.00 price objective on shares of Plexus in a research report on Thursday, July 24th. Benchmark reissued a "buy" rating and issued a $160.00 price objective on shares of Plexus in a research report on Wednesday, June 4th. Wall Street Zen lowered shares of Plexus from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 16th. Finally, Needham & Company LLC lowered their price target on shares of Plexus from $162.00 to $158.00 and set a "buy" rating on the stock in a research report on Thursday, July 24th. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $152.00.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.